| 1 |
Yan LH, Hu XH, Chen RX, Pan MM, Han YC, Gao M, Liu H. Plasmapheresis compared with conventional treatment for hypertriglyceridemia-induced acute pancreatitis: A systematic review and meta-analysis. J Clin Apher 2023;38:4-15. [PMID: 36151902 DOI: 10.1002/jca.22018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
He W, Cai W, Yang X, Camilleri G, Zheng X, Wang Q, Li Y, Mukherjee R, Huang W, Sutton R. Insulin or blood purification treatment for hypertriglyceridaemia-associated acute pancreatitis: A systematic review and meta-analysis. Pancreatology 2022;22:846-57. [PMID: 35981949 DOI: 10.1016/j.pan.2022.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Zhang Y, Lin J, Wu L, Lin J, Liang Y. Blood Purification for Hypertriglyceridemia-Induced Acute Pancreatitis: A Meta-analysis. Pancreas 2022;51:531-9. [PMID: 35858225 DOI: 10.1097/MPA.0000000000002071] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Wang X, Cai H, Chen Z, Zhang Y, Wu M, Xu X, Yang L. Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis. Int Immunopharmacol 2021;:108315. [PMID: 34785144 DOI: 10.1016/j.intimp.2021.108315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Pu W, Luo G, Chen T, Jing L, Hu Q, Li X, Xia H, Deng M, Lü M, Chen X. A 5-Year Retrospective Cohort Study: Epidemiology, Etiology, Severity, and Outcomes of Acute Pancreatitis. Pancreas 2020;49:1161-7. [PMID: 32897999 DOI: 10.1097/MPA.0000000000001637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 6 |
Guo Y, Cao F, Li C, Yang H, Xia S, Li F. Continuous Hemofiltration Reduces Mortality in Severe Acute Pancreatitis: A Meta-Analysis. Emerg Med Int 2020;2020:6474308. [PMID: 32670639 DOI: 10.1155/2020/6474308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Shan Y, Kong W, Zhu A, Zhang J, Ying R, Zhu W. Increased levels of miR-372 correlate with disease progression in patients with hyperlipidemic acute pancreatitis. Exp Ther Med 2020;19:3845-50. [PMID: 32346449 DOI: 10.3892/etm.2020.8609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Tabone R, Burstow MJ, Vardesh DL, Yuide PJ, Gundara J, Chua TC. Anti-lipid therapy and risk factor management for triglyceridaemia-induced acute pancreatitis. ANZ J Surg 2020;90:1997-2003. [PMID: 32190973 DOI: 10.1111/ans.15829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
